Search research articles
Contact Us
Filters
Showing results (281-290 of 299) with videos related to
Page
of 30
Sort By:
Cancer
|
December 26, 2001
OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisal
C van Haaften-Day, Y Shen, F Xu, et al.
Cancer Research
|
March 25, 1992
Overexpression and mutation of p53 in endometrial carcinoma
M F Kohler, A Berchuck, A M Davidoff, et al.
Oncogene
|
February 15, 2001
Functional evidence for an ovarian cancer tumor suppressor gene on chromosome 22 by microcell-mediated chromosome transfer
R P Kruzelock, B D Cuevas, J R Wiener, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 14, 2005
New tumor markers: CA125 and beyond
R C Bast, D Badgwell, Z Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2001
Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer
E Rivera, V Valero, L Syrewicz, et al.
Cancer Research
|
September 15, 2000
The human ARHI tumor suppressor gene inhibits lactation and growth in transgenic mice
F Xu, W Xia, R Z Luo, et al.
The New England Journal of Medicine
|
October 13, 1983
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer
R C Bast, T L Klug, E St John, et al.
The American Journal of Medicine
|
March 1, 1980
High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activity
E Frei, R H Blum, S W Pitman, et al.
Oncogene
|
September 15, 2015
Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway
J Chen, M Bai, C Ning, et al.
Oncogenesis
|
December 20, 2016
Linking genomic reorganization to tumor initiation via the giant cell cycle
N Niu, J Zhang, N Zhang, et al.
Page
of 30
Search research articles
Search
Showing results (281-290 of 299) with videos related to
Sort By:
Page
of 30
Cancer
|
December 26, 2001
OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisal
C van Haaften-Day, Y Shen, F Xu, et al.
Cancer Research
|
March 25, 1992
Overexpression and mutation of p53 in endometrial carcinoma
M F Kohler, A Berchuck, A M Davidoff, et al.
Oncogene
|
February 15, 2001
Functional evidence for an ovarian cancer tumor suppressor gene on chromosome 22 by microcell-mediated chromosome transfer
R P Kruzelock, B D Cuevas, J R Wiener, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 14, 2005
New tumor markers: CA125 and beyond
R C Bast, D Badgwell, Z Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2001
Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer
E Rivera, V Valero, L Syrewicz, et al.
Cancer Research
|
September 15, 2000
The human ARHI tumor suppressor gene inhibits lactation and growth in transgenic mice
F Xu, W Xia, R Z Luo, et al.
The New England Journal of Medicine
|
October 13, 1983
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer
R C Bast, T L Klug, E St John, et al.
The American Journal of Medicine
|
March 1, 1980
High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activity
E Frei, R H Blum, S W Pitman, et al.
Oncogene
|
September 15, 2015
Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway
J Chen, M Bai, C Ning, et al.
Oncogenesis
|
December 20, 2016
Linking genomic reorganization to tumor initiation via the giant cell cycle
N Niu, J Zhang, N Zhang, et al.
Page
of 30